Antiviral activity of an intracellularly expressed single-chain antibody fragment directed against the murine leukemia virus capsid protein

Human Gene Therapy

Volumn 11, Issue 3, 2000, Pages 389-401

  Marin, Mariana ^a   Pelegrin Zurilla, Mireia ^a   Bachrach, Estanislao ^a   Noël, Danièle ^a   Brockly, Frédérique ^a   Piechaczyk, Marc ^a  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CAPSID PROTEIN; MONOCLONAL ANTIBODY; PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; CERCOPITHECIDAE; CONTROLLED STUDY; GENE TRANSFER; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; VIRUS CAPSID; VIRUS INFECTION; VIRUS PARTICLE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BASE SEQUENCE; CAPSID; CELL EXTRACTS; CELL LINE; CLONING, MOLECULAR; IMMUNOBLOTTING; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA VIRUS, MURINE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RATS; RETROVIRIDAE PROTEINS, ONCOGENIC; TRANSFECTION; VIRAL ENVELOPE PROTEINS;

ANIMALIA; CERCOPITHECIDAE; MIRIDAE; MURINAE; MURINE LEUKEMIA VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0034628469     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050015860     Document Type: Article

References (58)

1. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A., and STRUHL, K. (1993). Current Protocols in Molecular Biology. (John Wiley & Sons, New York).
2. BALTIMORE, D. (1988). Intracellular immunization. Nature (London) 335, 395-396.
3. BIOCCA, S., PIERANDREI-AMALDI, P., CAMPIONI, N., and CATTANEO, A. (1994). Intracellular immunization with cytosolic recombinant antibodies. Bio/Technology 12, 396-399.
4. BUONOCORE, L., and ROSE, J.K. (1993). Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat. Proc. Natl. Acad. Sci. U.S.A. 90, 2695-2699.
5. CHEN, S.Y., BAGLEY, J., and MARASCO, W.A. (1994a). Intracellular antibodies as anew class of therapeutic molecules for gene therapy. Hum. Gene Ther. 5, 595-601.
6. CHEN, S.Y., KHOURI, Y., BAGLEY, J., and MARASCO, W.A. (1994b). Combined intra-and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody. Proc. Natl. Acad. Sci. U.S.A. 91, 5933-5936.
7. CHESBERO, B., BRITT, W., EVANS, L., WEHRY, K., NISHIO, J., and CLOYD, M. (1983). Characterization of monoclonal antibodies reactive with murine leukemia viruses: Use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus. Virology 127, 134-148.
8. CORBIN, A., PRATS, A.C., DARLIX, J.L., and SITBON, M. (1994). A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. J. Virol. 68, 3857-3867.
9. COSSET, F.L., TAKEUCHI, Y., BATTINI, J.L., WEISS, R.A., and COLLINS, M.K.L. (1995). High titer retroviral packaging systems which produce human complement-resistant retroviral vectors. J. Virol. 69, 7430-7436.
10. DUAN, L., BAGASRA, O., LAUGHLIN, M.A., OAKES, J.W., and POMERANTZ, R.J. (1994a). Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proc. Natl. Acad. Sci. U.S.A. 91, 5075-5079.
11. DUAN, L., ZHANG, H., OAKES, J.W., BAGASRA, O., and POMERANTZ, R.L. (1994b). Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains. Hum. Gene Ther. 5, 1315-1324.
12. DUAN, L., ZHU, M., BAGASRA, O., and POMERANTZ, R.J. (1995). Intracellular immunization against HIV-1 infection of human T lymphocytes: Utility of anti-Rev single-chain variable fragments. Hum. Gene Ther. 6, 1561-1573.
13. EVAN, G.I., LEWIS, G.K., RAMSAY, G., and BISHOP, L.M. (1985). Isolation of monoclonal antibodies specific for human c-myc protooncogene product. Mol. Cell. Biol. 5, 3610-3616.
14. EVANS, L.H., MORRISON, R.P., MALIK, F.G., PORTIS, J., and BRITT, W.J. (1990). A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J. Virol. 64, 6176-6183.
15. FRIEDMAN, A.D., TRIEZENBERG, S.J., and MCKNIGHT, S.L. (1988). Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus. Nature (London) 335, 452-454.
16. FUJISAWA, R., MCATEE, F.J., ZIRBEL, J.H., and PORTIS, J.L. (1997). Characterization of glycosylated Gag expressed by a neurovirulent murine leukemia virus: Identification of differences in processing in vitro and in vivo. J. Virol. 71, 5355-5360.
17. GANNON, J.V., GREAVES, R., IGGO, R., and LANE, D.P. (1990). Activating mutations in p53 produce common conformation effects. A monoclonal antibody specific for the mutant form. EMBO J. 9, 1595-1602.
18. GARGANO, N., and CATTANEO, A. (1997). Inhibition of murine leukaemia virus retrotranscription by the intracellular expression of a phage-derived anti-reverse transcriptase antibody fragment. J. Gen. Virol. 78, 2591-2599.
19. GREEN, G., ISHINO, M., and LOEWENSTEIN, P.M. (1989). Mutational analysis of HIV-1 tat minimal domain peptides: Identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression. Cell 58, 215-223.
20. HANSEN, M., JELINEK, L., JONES, R.S., STEGEMAN-OLSEN, J., and BARKLIS, E. (1993). Assembly and composition of intracellular particles formed by Moloney murine leukemia virus. J. Virol. 67, 5163-5174.
21. HARLOW, E., and LANE, D. (1988). Antibodies: A Laboratory Manual. E. Harlow and D. Lane, eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
22. HOOGENBOOM, H.R., GRIFFITHS, A.D., JOHNSON, K.S., CHISWELL, D.J., HUDSON, P., and WINTER, G. (1991). Multisubunit proteins on the surface of filamentous phage: Methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 19, 4133-4137.
23. KABAT, E.A., WU, T.T., PERRY, H.M., GOTTESMAN, K.S., and FOELLER, C. (1991). Sequences of Proteins of Immunological Interest. Series. (U.S. Department of Health and Human Services, National Institutes of Health, Bethesda, MD).
24. LAEMMLI, U.K. (1970). Cleavage of structural polyproteins during the assembly of the bacteriophage T4. Nature (London) 227, 680-685.
25. LANDER, M.R., and CHATTOPADHYAY, S.K. (1984). A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ecotropic, amphotropic, xenotropic, and mink cell focus-forming viruses. J. Virol. 52, 695-698.
26. LEVIN, R., MHASHILKAR, A.M., DORFMAN, T., BUKOVSKY, A., ZANI, C., BAGLEY, J., HINKULA, J., NIEDRIG, M., ALBERT, J., WAHREN, B., GOTTLINGER, H.G., and MARASCO, W.A. (1997). Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17. Mol. Med. 3, 96-110.
27. LEVY-MINTZ, P., DUAN, L., ZHANG, H., HU, B., DORNADULA, G., ZHU, M., KULKOSKY, J., BIZUB-BENDER, D., SKALKA A.M., and POMERANTZ, R.J. (1996). Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. J. Virol. 70, 8821-8832. [Published erratum appears in J. Virol. 1998;72:3505-3506].
28. MACKETT, M., LITTLER, E., MICHAEL, R., GARTLAND, M., and ARRAND, J.R. (1990). Vectors with multiple insertion sites for expression of cloned genes by T7 RNA polymerase: Expression of a peptide from EBV thymidine kinase. Nucleic Acids Res. 18, 1082.
29. MALIM, M.H., BOHNLEIN, S., HAUBER, J., and CULLEN, B.R. (1989). Functional dissection of the HIV-1 rev transactivator: Derivation of a trans-dominant repressor of rev function. Cell 58, 205-214.
30. MANN, R., MULLIGAN, R.C., and BALTIMORE, D. (1983). Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33, 153-159.
31. MARASCO, W.A. (1995). Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy. Immunotechnologies 1, 1-19.
32. MARASCO, W.A., HASELTINE, W.A., and CHEN, S.Y. (1993). Design, intracellular expression and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. Natl. Acad. Sci. U.S.A. 90, 7889-7893.
33. MARIN, M., BROCKLY, F., NOËL, D., ETIENNE-JULAN, M., HUA, T.D., GU, Z.J., PIECHACZYK-BIARD, M., and PIECHACZYK, M. (1995). Cloning and expression of a single-chain antibody fragment specific for a monomorphic determinant of class I molecules of the human major histocompatibility complex. Hybridoma 14, 443-451.
34. MCATEE, F.J., and PORTIS, J.L. (1985). Monoclonal antibodies specific for wild mouse neurotropic retrovirus: Detection of comparable levels of virus replication in mouse strains susceptible and resistant to paralytic disease. J. Virol. 56, 1018-1022.
35. MHASHILKAR, A.M., BAGLEY, J., CHEN, S.Y., SZILVAY, A.M., HELLAND, D.G., and MARASCO, W.A. (1995). Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J. 14, 1542-1551.
36. MORGENSTERN, J.P., and LAND, H. (1990). A series of mammalian expression vectors and characterization of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res. 18, 1068.
37. gag is nucleus associated in murine leukemia virus-infected cells. J. Virol. 67, 1350-1356.
38. PALU, G. (1997). Combined strategies for gene therapy of AIDS. Gene Ther. 4, 179-180.
39. PELEGRIN, M., MARIN, M., NOËL, D., and PIECHACZYK, M. (1998). Genetically engineered antibodies in gene transfer and gene therapy. Hum. Gene Ther. 9, 2165-2175.
40. PERSIC, L., RIGHI, M., ROBERTS, A., HOOGENBOOM, H.R., CATTANEO, A., and BRADBURY, A. (1997). Targeting vectors for intracellular immunisation. Gene 187, 1-8.
41. PORTIS, J.L., SPANGRUDE, G.J., and MCATEE, F.J. (1994). Identification of a sequence in the unique 5′ open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus. J. Virol. 68, 3879-3887.
42. RICHARDSON, J.H., and MARASCO, W.A. (1995). Intracellular antibodies: Development and therapeutical potential. Trends Biotechnol. 13, 306-310.
43. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
44. SARVER, N., CANTIN, E.M., CHANG, P.S., ZAIA, J.A., LADNE, P.A., STEPHENS, D.A., and ROSSI, J.J. (1990). Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247, 1222-1225.
45. SCHWARTZBERG, P., COLICELLI, J., GORDON, M.L., and GOFF, S.P. (1984). Mutations in the gag gene of Moloney murine leukemia virus: Effects on production of virions and reverse transcriptase. J. Virol. 49, 918-924.
46. SCZAKIEL, G., and PAWLITA, M. (1991). Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA. J. Virol. 65, 468-472.
47. SITBON, M., NISHIO, J., WEHRLY, K., LODMELL, D., and CHESEBRO, B. (1985). Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: Distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses. Virology 141, 110-118.
48. SMYTHE, J.A., SUN, D., THOMAS, M., MARKHAM, P.D., REITZ, M.S., GALLO, R.C., and LISZIEWICZ, J. (1994). A rev-inducible mutant gag gene stably transferred into T lymphocytes: An approach to gene therapy against human immunodeficiency virus type 1 infection. Proc. Natl. Acad. Sci. U.S.A. 91, 3657-3661.
49. SULLENGER, B., GALLARDO, H.F., UNGERS, G.E., and GILBOA, E. (1990). Overexpression of Tar sequences renders cells resistant to human immunodeficiency virus replication. Cell 63, 601-608.
50. SWANSTROM, R., and WILLS, J.W. (1997). Synthesis, assembly and processing of viral proteins. In Retroviruses . J.M. Coffin, S.H. Hughes, and H.E. Varmus, eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
51. TAKAHARA, Y., HAMADA K., and HOUSMAN, D.E. (1992). A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes. J. Virol. 66, 3725-3732.
52. TRONO, D., FEINBERG, M.B., and BALTIMORE, D. (1989). HIV-1 gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59, 113-120.
53. WARD, E.S., GÜSSOW, D., GRIFFITHS, A.D., JONES, P.T., and WINTER, G. (1989). Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature (London) 341, 544-546.
54. WEISS, R., TEICH, N., VARMUS, H., and COFFIN, J. (1984). RNA Tumor Viruses. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
55. WILLS, J.W., and CRAVEN, R.C. (1991). Form, function and use of retroviral Gag proteins. AIDS 5, 639-654.
56. WU, Y., DUAN, L., ZHU, M., HU, B., KUBOTA, S., BAGASRA, O., and POMERANTZ, R.J. (1996). Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 Rev: Variations in viral inhibition. J. Virol. 70, 3290-3297.
57. YANG, A.-G., and CHEN, S.-Y. (1997). A new class of antigen-specific killer cells. Nature Biotechnol. 15, 46-50.
58. YU, M., POESCHLA, E., and WONG-STAAL, F. (1994). Progress towards gene therapy for HIV infection. Gene Ther. 1, 13-20.